3ATQ image
Entry Detail
PDB ID:
3ATQ
Keywords:
Title:
Geranylgeranyl Reductase (GGR) from Sulfolobus acidocaldarius
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2011-01-12
Release Date:
2011-05-04
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Conserved Archaeal protein
Chain IDs:A
Chain Length:453
Number of Molecules:1
Biological Source:Sulfolobus acidocaldarius
Primary Citation
Structure and mutation analysis of archaeal geranylgeranyl reductase
J.Mol.Biol. 409 543 557 (2011)
PMID: 21515284 DOI: 10.1016/j.jmb.2011.04.002

Abstact

The crystal structure of geranylgeranyl reductase (GGR) from Sulfolobus acidocaldarius was determined in order to elucidate the molecular mechanism of the catalytic reaction. The enzyme is a flavoprotein and is involved in saturation of the double bonds on the isoprenoid moiety of archaeal membranes. The structure determined in this study belongs to the p-hydroxybenzoate hydroxylase family in the glutathione reductase superfamily. GGR functions as a monomer and is divided into the FAD-binding, catalytic and C-terminal domains. The catalytic domain has a large cavity surrounded by a characteristic YxWxFPx(7-8)GxG motif and by the isoalloxazine ring of an FAD molecule. The cavity holds a lipid molecule, which is probably derived from Escherichia coli cells used for over-expression. One of the two forms of the structure clarifies the presence of an anion pocket holding a pyrophosphate molecule, which might anchor the phosphate head of the natural ligands. Mutational analysis supports the suggestion that the three aromatic residues of the YxWxFPx(7-8)GxG motif hold the ligand in the appropriate position for reduction. Cys47, which is widely conserved in GGRs, is located at the si-side of the isoalloxazine ring of FAD and is shown by mutational analysis to be involved in catalysis. The catalytic cycle, including the FAD reducing factor binding site, is proposed on the basis of the detailed analysis of the structure.

Legend

Protein

Chemical

Disease

Primary Citation of related structures